Population pharmacokinetics and dose regimen evaluation of monalizumab, a monoclonal antibody targeting NKG2a, in patients with advanced solid tumors

Song, XY

CANCER RESEARCH, 2020; 80 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索